Ocugen Inc Stock Today
| OCGN Stock | USD 1.32 0.12 8.33% |
Performance16 of 100
| Odds Of DistressLess than 13
|
Ocugen is selling at 1.32 as of the 19th of April 2024; that is -8.33 percent decrease since the beginning of the trading day. The stock's open price was 1.44. Ocugen has less than a 13 % chance of experiencing some financial distress in the next two years of operation and had a solid performance during the last 90 days. Equity ratings for Ocugen Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 3rd of December 2014 | Category Healthcare | Classification Health Care |
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company has 257.32 M outstanding shares of which 43.48 M shares are now shorted by private and institutional investors with about 4.05 trading days to cover. More on Ocugen Inc
Moving against Ocugen Stock
| 0.61 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 3rd of May 2024
Ocugen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Ocugen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Ocugen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO CoFounder | Shankar MBA | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation Analysts covering Ocugen report their recommendations after researching Ocugen's financial statements, talking to executives and customers, or listening in on Ocugen's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Ocugen Inc. The Ocugen consensus assessment is calculated by taking the average forecast from all of the analysts covering Ocugen. | |||||
Ocugen's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Ocugen's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Ocugen's financial leverage. It provides some insight into what part of Ocugen's total assets is financed by creditors.
| |||||
Ocugen Inc (OCGN) is traded on NASDAQ Exchange in USA. It is located in 263 Great Valley Parkway, Malvern, PA, United States, 19355 and employs 15 people. Ocugen is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 370.55 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ocugen's market, we take the total number of its shares issued and multiply it by Ocugen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Ocugen Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 257.32 M outstanding shares of which 43.48 M shares are now shorted by private and institutional investors with about 4.05 trading days to cover.
Ocugen Inc currently holds about 101.6 M in cash with (62.05 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.46.
Check Ocugen Probability Of Bankruptcy
Ownership AllocationOcugen Inc has a total of 257.32 Million outstanding shares. Roughly 88.0 pct. of Ocugen outstanding shares are held by general public with 1.45 % owned by insiders and only 10.33 (%) by third-party entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Ocugen Ownership Details
Ocugen Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Ocugen jumping above the current price in 90 days from now is about 25.96%. The Ocugen Inc probability density function shows the probability of Ocugen stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.8196. This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Ocugen will likely underperform. Moreover, ocugen Inc has an alpha of 1.4804, implying that it can generate a 1.48 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Ocugen to move above the current price in 90 days from now is about 25.96 (This Ocugen Inc probability density function shows the probability of Ocugen Stock to fall within a particular range of prices over 90 days) .
Ocugen Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Ocugen that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Ocugen's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Ocugen's value.| Instituion | Recorded On | Shares | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 296.2 K | |
| Cubist Systematic Strategies, Llc | 2023-12-31 | 265.5 K | |
| Renaissance Technologies Corp | 2023-12-31 | 246.2 K | |
| T. Rowe Price Associates, Inc. | 2023-12-31 | 187.1 K | |
| Jpmorgan Chase & Co | 2023-12-31 | 182.8 K | |
| Charles Schwab Investment Management Inc | 2023-12-31 | 170.3 K | |
| Two Sigma Investments Llc | 2023-12-31 | 157.3 K | |
| Bank Of America Corp | 2023-12-31 | 155.2 K | |
| D. E. Shaw & Co Lp | 2023-09-30 | 139 K | |
| Vanguard Group Inc | 2023-12-31 | 12 M | |
| Blackrock Inc | 2023-12-31 | 3.7 M |
Ocugen Historical Income Statement
Ocugen Inc Income Statement is one of the three primary financial statements used for reporting Ocugen's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Ocugen Inc revenue and expense. Ocugen Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Ocugen's Cost Of Revenue is very stable compared to the past year. View More FundamentalsOcugen Stock Against Markets
Picking the right benchmark for Ocugen stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Ocugen stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Ocugen is critical whether you are bullish or bearish towards Ocugen Inc at a given time. Please also check how Ocugen's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Ocugen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Valuation Now
Equity ValuationCheck real value of public entities based on technical and fundamental data |
| All Next | Launch Module |
Ocugen Corporate Management
Elected by the shareholders, the Ocugen's board of directors comprises two types of representatives: Ocugen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ocugen. The board's role is to monitor Ocugen's management team and ensure that shareholders' interests are well served. Ocugen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ocugen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Durgaprasad Annavajjula | Head VP | Profile | |
| CPA CPA | Sr Officer | Profile | |
| Michael Shine | VP Commercial | Profile | |
| Michael MBA | Senior Commercial | Profile | |
| Arun Upadhyay | Chief Development | Profile | |
| Uday Kompella | Cofounder Director | Profile |
How to buy Ocugen Stock?
Before investing in Ocugen, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Ocugen. To buy Ocugen stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Ocugen. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Ocugen stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Ocugen Inc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Ocugen Inc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Ocugen Inc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Ocugen Stock please use our How to Invest in Ocugen guide.
Already Invested in Ocugen Inc?
The danger of trading Ocugen Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Ocugen is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Ocugen. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Ocugen Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Ocugen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ocugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ocugen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ocugen Inc Stock: Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocugen Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Ocugen Inc information on this page should be used as a complementary analysis to other Ocugen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Complementary Tools for Ocugen Stock analysis
When running Ocugen's price analysis, check to measure Ocugen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocugen is operating at the current time. Most of Ocugen's value examination focuses on studying past and present price action to predict the probability of Ocugen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocugen's price. Additionally, you may evaluate how the addition of Ocugen to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Ocugen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocugen. If investors know Ocugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.26) | Revenue Per Share 0.025 | Quarterly Revenue Growth 1.426 | Return On Assets (0.47) | Return On Equity (1.01) |
The market value of Ocugen Inc is measured differently than its book value, which is the value of Ocugen that is recorded on the company's balance sheet. Investors also form their own opinion of Ocugen's value that differs from its market value or its book value, called intrinsic value, which is Ocugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocugen's market value can be influenced by many factors that don't directly affect Ocugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.